Czechia· CZ-0027700
TARGRETIN
A bexarotene product containing bexarotene, registered in Czechia by H.A.C. Pharma, Caen. The same ATC class is registered in 13 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Bexarotene is registered in 13 of 19 countries.
Countries holding a registration under ATC L01XF03 (bexarotene), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 8 of them publish a price we can compare per daily dose
Bexarotene · ATC L01XF03
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- BEXAROTENE
- Manufacturer
- H.A.C. Pharma, Caen
- Country
- Czechia (CZ)
- ATC code
- L01XF03
- ATC class
- Bexarotene
- Defined daily dose
- 0.54 g, O
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- cz_kod_sukl0027700100CZK 26080.55
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
573 interactions on record for bexarotene.
Graded by severity as the source publishes them — 127 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bexarotene · interactions on record
573 records
- 127 severe
- 357 moderate
- 80 minor
- 9 info
Most severe, free to view
- EluxadolineA07DA06severe
- LiraglutidA08AX02severe
- SemaglutidA08AX03severe
- SitagliptinA10BH01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Bexarotene in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesbexaroteneActavis Pharma, Inc.
- FinlandBexarotene AmdipharmAmdipharm Limited
- NorwayBexarotene AmdipharmAmdipharm Limited
- FranceBEXAROTENE CIPLA 75 mg, capsule molleCIPLA EUROPE (BELGIQUE)
- SwedenBexarotene Amdipharm 75 mg Kapsel, mjukAmdipharm Limited
- SpainBEXAROTENO CIPLA 75 MG CAPSULAS BLANDAS EFGCipla Europe N.V.
- IcelandTargretinH.A.C. Pharma
- IrelandTargretin 75 mg soft capsulesH.A.C Pharma
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Bexagia
- Germany · Bexaroten Cipla
- Denmark · Bexarotene
- Spain · Bexaroteno Cipla
- Finland · Bexarotene Amdipharm
- France · Bexarotene Cipla
- United Kingdom (Northern Ireland) · Bexarotene Genus Pharmaceuticals Ltd.
- Iceland · Targretin
- Italy · Bexarotene Cipla
- Liechtenstein · Targretin
- Norway · Bexarotene Amdipharm, Targretin
- Sweden · Bexarotene Amdipharm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1e95c15f-4a30-4ca2-abd4-b66230b929ea GET /v1/drugs/1e95c15f-4a30-4ca2-abd4-b66230b929ea?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "CPS MOL",
"source": "sukl",
"strength": "75MG",
"pack_size": "100",
"substance": "BEXAROTENE",
"cz_kod_sukl": "0027700",
"product_type": "CH",
"substance_codes": "15568",
"registration_state": "R",
"registration_number": "EU/1/01/178/001"
}See everything about bexarotene.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.